ArticleNature communications2020

Interference with ERK-dimerization at the nucleocytosolic interface targets pathological ERK1/2 signaling without cardiotoxic side-effects.

Angela Tomasovic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.